
AT&T announced on Tuesday, February 1, that it will spin off WarnerMedia, home to HBO and CNN, in a US$43 billion deal to merge the property with Discovery, reported the Wall Street Journal.
The telecom giant also cut its dividend by nearly half, sending shares down over 6% in pre-market trading.
After the spinoff, AT&T stated it expects to pay an annual per-share dividend of about US$1.11, down from its most recent US$2.08 level. The new payout would cost the company just under US$8 billion a year, down from the roughly US$15 billion it paid out in 2021.
AT&T stated the change accounts for the media-asset distribution and supports the telecom company’s plans to boost investment in 5G wireless and fiber-optic service. Reducing the size of the dividend will also allow the business to more quickly whittle down debt. The company has said it will remain one of corporate America’s highest dividend-yield payers after the spinoff.
AT&T executives had said they would cut the dividend to reflect the company’s smaller size once the media business is carved out into a separate company. The stand-alone telecom company stands to get about US$43 billion in cash from the transaction, subject to certain adjustments.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas